Company intelligence / Profile preview

Lemme

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Lemme produces plant-based, science-backed vitamins and botanical supplements that are marketed to support general well-being, weight management, and appetite regulation, leveraging clinically studied ingredients such as Eriomin Lemon Fruit Extract, Supresa Saffron Extract, and Morosil Red Orange Fruit Extract[1]. Their flagship product, Lemme GLP-1 Daily, is positioned as a natural GLP-1 supplement (not a synthetic GLP-1 agonist drug) with ingredients shown to boost GLP-1 levels and aid in weight management[1]. The brand emphasizes clinically validated, vegan, gluten-free, non-GMO, and clean formulations[1][5].

Therapeutic areas: Endocrinology
Modalities: Botanical extractNatural supplement
Industry: Food & Nutrition

Partnerships

Exclusive North American Food, Drug, Mass & Club license for Eriomin Lemon Fruit Extract

Beyond the preview

Go deeper on Lemme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lemme.

Explore the full profile